LUCD
Lucid Diagnostics Inc.
NASDAQ · Healthcare · Medical - Devices · US
$0.94
−1.23%Margins
Gross margin
-25.8%
EBITDA margin
-943.4%
EBIT margin
-930.9%
Net margin
-959.8%
FCF margin
-866.6%
-478.3%
Return on equity
-134.2%
Return on assets
-141.4%
Return on invested capital
0.15x
Asset turnover
-$46.9M
Cash from operations
$0.17
Cash per share
Margins, returns on capital and operating efficiency from the latest trailing period · Data as of Jun 1, 2026